Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Siltuximab (Sylvant®)
Siltuximab (Sylvant®)
- Traffic Light
Red
- BNF
- Licensed Indicators
Treatment of adult patients with multicentric Castlemans disease who are HIV-negative and human herpesvirus-8 negative
- Reference
APC Aug 14
- Criteria
- Provisional
Yes
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik